Science Explorer Back to mapMap
Discussion
Researcher · Actelion (Switzerland) · Switzerland

Lilla Di Scala

Lilla Di Scala publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Statistics and Probability, on topics such as Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management and Statistical Methods in Clinical Trials.

OpenAlex
World rank
#1,001,319
of 7,710,434 ranked researchers
Rank in Switzerland
#17,236
of 80,918
Works
58
Citations
2.5k
Citations per work
43.9
h-index
20
i10-index 20Top 19% in Pulmonary and Respiratory Medicine
Lilla Di Scala

What does Lilla Di Scala research?

Lilla Di Scala's work is mostly in Medicine (50%), Mathematics (8%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 29 works · 49.7% of their workMedicine: 29 works · 49.7% of their workPulmonary and Respiratory Medicine: 17 works · 30.1% of their workCardiology and Cardiovascular Medicine: 5 works · 8.4% of their workOncology: 4 works · 7.7% of their workSurgery: 2 works · 3.5% of their workEverything else: 23 works · 39.1% of their workPhysical Sciences: 4 works · 7.7% of their workMathematics: 4 works · 7.7% of their workStatistics and Probability: 4 works · 7.7% of their workLife Sciences: 2 works · 3.5% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 3.5% of their workMolecular Biology: 2 works · 3.5% of their workTHEIR WORKLilla Di Scala58works
Life Sciences4%Physical Sciences8%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2949.7%
  2. Everything else2339.1%
    1. Mathematics47.7%
    1. Biochemistry, Genetics and Molecular Biology23.5%
  1. 1Pulmonary and Respiratory Medicine30% of their works
  2. 2Cardiology and Cardiovascular Medicine8% of their works
  3. 3Statistics and Probability8% of their works
  4. 4Oncology8% of their works
  5. 5Surgery4% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Lilla Di Scala's research?

The keywords of their largest research topics: Treatment Guidelines, Pulmonary Hypertension, Right Heart Assessment, Diagnosis, Biomarkers, Clinical Trials, Targeted Therapy and Guidelines.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Treatment Guidelines292 topics
  2. Pulmonary Hypertension231 topic
  3. Right Heart Assessment231 topic
  4. Diagnosis122 topics
  5. Biomarkers112 topics
  6. Clinical Trials102 topics
  7. Targeted Therapy102 topics
  8. Guidelines81 topic
  9. Heart Failure81 topic
  10. Adaptive Designs71 topic
  11. False Discovery Rate71 topic
  12. ALK Inhibitors61 topic
  13. EGFR Mutations61 topic
  14. COPD41 topic
  15. Fibrosis41 topic
  16. Genomic Profiles41 topic
  17. Idiopathic Pulmonary Fibrosis41 topic
  18. Inhaler Devices41 topic
  19. Pulmonary Drug Delivery41 topic
  20. Small-Cell Lung Cancer41 topic
  21. spirometry41 topic

Where does Lilla Di Scala work?

Lilla Di Scala's main affiliation in the publication record is Actelion (Switzerland), Switzerland.

How many publications and citations does Lilla Di Scala have?

OpenAlex counts 58 works and 2,544 citations for Lilla Di Scala, an h-index of 20, ranking #1,001,319 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lilla Di Scala. Posts are plain text and can be reported.